Consolidated Entities - Pulmoquine Therapeutics, Inc. (Details) - USD ($) $ in Thousands	1 Months Ended
	Apr. 30, 2020	Mar. 31, 2021	Dec. 31, 2020	[1]
Consolidated Entities
Total assets		$ 1,088,290	$ 999,570
Pulmoquine Therapeutics, Inc.
Consolidated Entities
Total assets		$ 3,300
Pulmoquine Therapeutics, Inc. | Series A preferred stock
Consolidated Entities
Number of shares purchased under the securities purchase agreement	5,808,550
Payments to acquire equity securities	$ 5,000

[1] Consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements.